CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank33
3Y CAGR+25.7%
5Y CAGR-8.3%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+25.7%/yr
vs -23.6%/yr prior
5Y CAGR
-8.3%/yr
Recent acceleration
Acceleration
+49.3pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20253.09+146.8%
20241.25+6.6%
20231.17-24.5%
20221.55-61.0%
20213.98-16.2%
20204.76+34.2%
20193.54-22.1%
20184.55-28.4%
20176.36+20.8%
20165.26-